
理解市場 | 新華保險續漲近 5% 投資收益高增驅動淨利潤繼續高增

NCI continued to rise nearly 5%, as of the time of writing, up 4.89% to HKD 50.6, with a transaction volume of HKD 938 million. In terms of news, NCI recently announced that it expects the net profit attributable to shareholders for the first three quarters of 2025 to be between RMB 29.986 billion and RMB 34.122 billion, a year-on-year increase of 45% to 65%. Guojin Securities indicated that the company's Q3 single-quarter estimate is expected to be between RMB 15.187 billion and RMB 19.323 billion, an increase of RMB 5.590 billion to RMB 9.726 billion year-on-year, with a year-on-year growth of 58.2% to 101.3%. The high growth is expected to be mainly due to the company's high equity position and a greater allocation to growth styles. Looking ahead for the year, the strong foundation laid in H1 2025 is expected to achieve over 50% growth in NBV on a comparable basis for the full year, with profit growth expected to exceed 40% for the year under the positive outlook for the equity market
According to Zhitong Finance APP, NCI (01336) continued to rise nearly 5%, with a current increase of 4.89%, priced at HKD 50.6, and a trading volume of HKD 938 million.
On the news front, NCI recently announced that it expects the net profit attributable to shareholders for the first three quarters of 2025 to be between RMB 29.986 billion and RMB 34.122 billion, a year-on-year increase of 45% to 65%. Guojin Securities pointed out that the company's Q3 single-quarter estimate is expected to be between RMB 15.187 billion and RMB 19.323 billion, an increase of RMB 5.590 billion to RMB 9.726 billion year-on-year, with a year-on-year growth of 58.2% to 101.3%. The high growth is expected to be mainly due to the company's high equity position and a greater allocation to growth styles. Looking ahead for the year, the strong foundation laid in the first half of 2025 is expected to achieve over 50% growth in NBV on a comparable basis for the whole year, with profit growth expected to exceed 40% for the year under the favorable outlook for the equity market
